The Impact Of Treatment Adherence On Clinical And Economic Outcomes In Multiple Sclerosis: Real-World Evidence From Alberta, Canada

B. Gerber,T. Cowling,G. Chen, D. Rivest,M. M. Yeung,P. Duquette, C. Kindundu, M. Barbeau,P. Haddad

VALUE IN HEALTH（2016）

Cited 29|Views14

No score

Abstract

•Of Albertan MS patients identified, 66% were adherent to their prescribed DMT.•Adherent patients had ~ 20% less physician and ambulatory care visits than non-adherent patients.•Adherent patients had ~ 50% fewer hospitalizations than non-adherent patients.•These results highlight a significant impact of adherence to DMTs on healthcare utilization.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined